Bloomberg Law
Pharmaceutical & Life Sciences News

Latest Stories

AstraZeneca to Buy Fusion Pharma for Up to $2.4 Billion

AstraZeneca Plcagreed to buy <-rte-company state="{"_id":"0000018e-55e3-d509-adee-5df3a7540001","_type":"00000160-4b23-d8bd-adfd-4b3348fd0000"}">Fusion Pharmaceuticals Inc. for as much as $2.4 billion as it seeks to transform cancer treatment by replacing traditional methods like chemotherapy with more targeted approaches.

Health Care Hack Exposes Flaws and Danger of Apathy: Dave Lee

As senators squabble about the theoretical vulnerability of those who use TikTok, they might want to find more time to give greater consideration to a clear and present danger erupting within the US health-care system: the continuing cyberattack that has put at risk the medical data of 79 million Americans and thrown health-care services into disarray.

Intermittent Fasting Linked to Heart Risk in Study Surprise

The safety of <-bsp-bb-link state="{"bbHref":"bbg://screens/nse%20%22intermittent%20fasting%22%20bn","_id":"0000018e-538e-d509-adee-5bdfc6570000","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">intermittent fasting, a popular strategy to lose weight by limiting food intake to certain times, was called into question by a surprise finding from research presented at a medical meeting.